Chinese firms turned to science publications after US tech sanctions
Patent citations and research output surged among sanctioned Chinese companies
1Sanctions drove scientific engagement
Chinese firms placed on the US Entity List between 2010-2022 increased their reliance on scientific publications for innovation. These companies produced 72.3% more patents citing academic papers compared to similar non-sanctioned firms. The restrictions prevented access to proprietary US technologies, forcing alternative knowledge sourcing. Researchers analyzed data from China's patent office and Web of Science to measure this shift.
2Entity List's restrictive impact
The US Entity List bars listed companies from licensing certain materials and joint R&D projects. Initiated in 2018 amid US-China tensions, it aims to protect national security. Sanctioned firms couldn't access standard technology transfer channels, creating an innovation barrier. This policy had unintended consequences, pushing Chinese firms toward open scientific literature instead.
3Quantifying the publication surge
Sanctioned companies published 33.3% more papers in China's National Knowledge Infrastructure database than peers. Their Web of Science publications increased by 85.2%. While all Chinese firms increased scientific engagement during 2010-2022, sanctioned ones accelerated faster. CNIPA patents citing papers grew 18-fold overall, from 5,225 to 94,441 in the period.
4Comparative research methodology
The study matched 2010-2022 Entity List firms with comparable non-sanctioned companies by industry, ownership and location. Researchers used CNIPA patent data, Web of Science indexes, and stock market databases. This controlled for China's general science investment growth. The robust comparison isolated the sanctions' specific effect on innovation strategies.
5US still leads in patent science
Despite China's gains, US inventors maintain global leadership in applying scientific knowledge to patents. Chinese firms' USPTO patents grew 13-fold (452 to 6,071) but trail US quality. The data suggests sanctions prompted quantity over quality shifts. Chinese firms focused on measurable outputs like publication counts to demonstrate R&D progress.
6Policy paradox revealed
The findings show export controls can spur alternative innovation pathways rather than stifle capability. Stanford's Mistree notes this unintended consequence: sanctions intensified China's science focus beyond normal investment effects. The policy achieved opposite results by making open science more valuable than restricted proprietary knowledge.
7Limitations and open questions
Researchers can't prove sanctions solely caused the shift, as other factors may contribute. Singapore's Huang notes China's general science push coincided with sanctions. The study doesn't measure innovation quality or commercial success. It also can't predict long-term effects as geopolitical tensions continue evolving.
8Strategic implications
The research suggests knowledge restrictions may accelerate competitor nations' scientific capabilities. China's forced pivot to open science strengthened domestic research ecosystems. For policymakers, it demonstrates how control measures can produce counterintuitive outcomes in global innovation races, potentially reducing intended technological advantages.
Original article: Nature — Chinese firms turned to science publications after US tech sanctions